Literature DB >> 29928163

Shortening Treatment for Hepatitis C Virus Infection.

Shyam Kottilil1.   

Abstract

Entities:  

Year:  2018        PMID： 29928163      PMCID： PMC6004042     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Are we nearing the end in the fight against hepatitis C?

Authors:  Joel V Chua; Shyam Kottilil
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-03-28       Impact factor: 3.869

Review 2.  Shortening the duration of therapy for chronic hepatitis C infection.

Authors:  Benjamin Emmanuel; Eleanor M Wilson; Thomas R O'Brien; Shyam Kottilil; George Lau
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-08-10

3.  Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.

Authors:  Anita Kohli; Anuoluwapo Osinusi; Zayani Sims; Amy Nelson; Eric G Meissner; Lisa L Barrett; Dimitra Bon; Miriam M Marti; Rachel Silk; Colleen Kotb; Chloe Gross; Tim A Jolley; Sreetha Sidharthan; Tess Petersen; Kerry Townsend; D'Andrea Egerson; Rama Kapoor; Emily Spurlin; Michael Sneller; Michael Proschan; Eva Herrmann; Richard Kwan; Gebeyehu Teferi; Rohit Talwani; Gabbie Diaz; David E Kleiner; Brad J Wood; Jose Chavez; Stephen Abbott; William T Symonds; G Mani Subramanian; Phillip S Pang; John McHutchison; Michael A Polis; Anthony S Fauci; Henry Masur; Shyam Kottilil
Journal:  Lancet       Date:  2015-01-13       Impact factor: 79.321

4.  Four-Week Direct-Acting Antiviral Regimens in Noncirrhotic Patients With Hepatitis C Virus Genotype 1 Infection: An Open-Label, Nonrandomized Trial.

Authors:  Anita Kohli; Sarah Kattakuzhy; Sreetha Sidharthan; Amy Nelson; Mary McLaughlin; Cassie Seamon; Eleanor Wilson; Eric G Meissner; Zayani Sims; Rachel Silk; Chloe Gross; Elizabeth Akoth; Lydia Tang; Angie Price; Tim A Jolley; Benjamin Emmanuel; Michael Proschan; Gebeyehu Teferi; Jose Chavez; Stephen Abbott; Anuoluwapo Osinusi; Hongmei Mo; Michael A Polis; Henry Masur; Shyam Kottilil
Journal:  Ann Intern Med       Date:  2015-11-24       Impact factor: 25.391
  4 in total
  1 in total

1.  Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China.

Authors:  Hui Jun Zhou; Jing Cao; Hui Shi; Nasheen Naidoo; Sherehe Semba; Pei Wang; Yi Fan Fan; Shui Cheng Zhu
Journal:  Front Public Health       Date:  2021-12-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.